Mount Yale Investment Advisors, LLC Invitae Corp Transaction History

Mount Yale Investment Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$0.6 - $1.53 $3,870 - $9,868	-6,450 Reduced 31.14%	14,264 $8,000
Q2 2023 Aug 14, 2023	BUY	$1.05 - $1.63 $2,616 - $4,061	2,492 Added 13.68%	20,714 $23,000
Q1 2023 May 11, 2023	SELL	$1.2 - $2.73 $5,146 - $11,708	-4,289 Reduced 19.05%	18,222 $24,000
Q4 2022 Feb 13, 2023	SELL	$1.71 - $3.61 $408,358 - $862,089	-238,806 Reduced 91.39%	22,511 $41,000
Q3 2022 Nov 07, 2022	BUY	$1.9 - $8.63 $43,871 - $199,266	23,090 Added 9.69%	261,317 $643,000

Q2 2022 Aug 02, 2022	BUY	$2.13 - $9.01 $177,803 - $752,118	83,476 Added 53.94%	238,227 $581,000
Q1 2022 May 03, 2022	BUY	$6.28 - $15.59 $428,396 - $1.06 Million	68,216 Added 78.83%	154,751 $1.23 Million
Q4 2021 Feb 02, 2022	BUY	$14.7 - $28.67 $1.15 Million - $2.25 Million	78,547 Added 983.31%	86,535 $1.32 Million
Q3 2021 Nov 02, 2021	BUY	$24.31 - $33.6 $194,188 - $268,396	7,988 New	7,988 $227,000
Q4 2018 Feb 14, 2019	SELL	$9.26 - $16.38 $15,593 - $27,583	-1,684 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$7.54 - $18.31 $12,697 - $30,834	1,684 New	1,684 $24,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.